Currently, most results indicated that CMTM6 helps to establish an immunosuppressive microenvironment in many tumors, such as gliomas, renal carcinomas and colorectal cancer (CRC) (20, 27, 28). This evidence concerns the gene CMTM6 and renal carcinoma.